I'm not sure if Lucentis is classed as either of these. It is known as an Anti-angiogenic agent.
Anti-angiogenic ophthalmic agents act as vascular endothelial growth factor (VEGF) antagonists. When retinal pigment cells become ischemic and dry up VEGF stimulates generation of new blood vessels by a process called neovascularization. During the generation of new blood vessels in the retina, if the blood vessels do not generate properly it causes leaking. This can lead to loss of vision.
Anti-angiogenic ophthalmic agents are used to stop neovascularization in age related macular degeneration.
- Lucentis Information for Consumers
- Lucentis Information for Healthcare Professionals (includes dosage details)
- Side Effects of Lucentis (detailed)
Search for questions
Still looking for answers? Try searching for what you seek or ask your own question.
Posted 18 Jan 2010 • 1 answer
Posted 3 Apr 2011 • 1 answer
Posted 16 Jul 2012 • 2 answers
Posted 2 Jun 2014 • 1 answer
Posted 5 Feb 2016 • 1 answer